Remission in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study in France

European Psychiatry

Volumn 23, Issue 7, 2008, Pages 491-496

  Gasquet, Isabelle ^a,b   Haro, Josep Maria ^c   Tcherny Lessenot, Stéphanie ^d   Chartier, Florence ^d   Lépine, Jean Pierre ^e  

^a université Paris Cité   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Research and Development Unit   (Spain)

^d Lilly France   (France)

^e HÔPITAL FERNAND WIDAL   (France)

Author keywords

Antipsychotic agents; Remission; Schizophrenia

Indexed keywords

OLANZAPINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA;

ADULT; AMBULATORY CARE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; REMISSION INDUCTION; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 53449091044     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.03.012     Document Type: Article

References (26)

1. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162 (2005) 441-449
2. Breier A., Schreiber J.L., Dyer J., and Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 48 (1991) 239-246
3. Correll C.U., Malhotra A.K., Kaushik S., McMeniman M., and Kane J.M. Early prediction of antipsychotic response in schizophrenia. Am J Psychiatry 160 (2003) 2063-2065
4. Emsley R., Oosthuizen P.P., Kidd M., Koen L., Niehaus D.J., and Turner H.J. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 67 (2006) 1707-1712
5. Green A.L., Lieberman J.A., Hamer R.M., Glick I.D., Gur R.E., Kahn R.S., et al. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res 86 (2006) 234-243
6. Haro J.M., Edgell E.T., Frewer P., Alonso J., Jones P.B., and on behalf of the SOHO Study Group. The European Schizophrenia Outpatient Health Outcomes study: baseline findings across country and treatment. Acta Psychiatr Scand 107 (2003) 7-15
7. Haro J.M., Edgell E.T., Jones P.B., Alonso J., Gavart S., Gregor K.J., et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 107 (2003) 222-232
8. Haro J.M., Kamath S.A., Ochoa S., Novick D., Rele K., Fargas A., et al. The Clinical Global Impression Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand 107 (2003) 16-23
9. Haro J.M., Novick D., Belger M., Jones P.B., and the SOHO advisory board. Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia. Eur Psychiatry 21 (2006) 41-47
10. Haro J.M., Novick D., Suarez D., Alonso J., Lepine J.P., Ratcliffe M., et al. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. J Clin Psychopharmacol 26 (2006) 571-578
11. Haro J.M., Ochoa S., Gervin M., Mavreas V., and Jones P. Assessment of remission in schizophrenia with the CGI and CGI-SCH scales. Acta Psychiatr Scand 115 (2007) 163-164
12. Haro J.M., Suarez D., Novick D., Brown J., Usall J., and Naber D. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results. Eur Neuropsychopharmacol 17 (2007) 235-244
13. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 250 (2000) 274-285
14. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67 (2006) 1690-1697
15. Leucht S., and Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 67 Suppl. 5 (2006) 3-8
16. Leucht S., and Kane J.M. Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia. J Clin Psychiatry 67 (2006) 1813-1814
17. Leucht S., and Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39 (2006) 161-170
18. Liberman R.P., and Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv 56 (2005) 735-742
19. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 (2005) 1209-1223
20. Perkins D.O., Gu H., Boteva K., and Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162 (2005) 1785-1804
21. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., and Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 473-479
22. Rosen K., and Garety P. Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 31 (2005) 735-750
23. Sethuraman G., Taylor C.G., Enerson M., and Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res 79 (2005) 337-340
24. Tandon R., Targum S.D., Nasrallah H.A., and Ross R. Treatment Effectiveness in Schizophrenia Consortium. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J Psychiatr Pract 12 (2006) 348-363
25. Uçok A., Polat A., Genç A., Cakir S., and Turan N. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 38 (2004) 163-168
26. Van Os J., Burns T., Cavallaro R., Leucht S., Peuskens J., Helldin L., et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 113 (2006) 91-95